FDA allows marketing of consumer genetic tests

On April 6, the U.S. Food and Drug Administration (FDA) announced it was allowing marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or conditions. These are the first direct-to-consumer genetic tests that the FDA as authorized. Read more 

LEAVE A REPLY

Please enter your comment!
Please enter your name here